Atossa Genetics Revenue and Competitors
Estimated Revenue & Valuation
- Atossa Genetics's estimated annual revenue is currently $1.7M per year.
- Atossa Genetics's estimated revenue per employee is $77,273
- Atossa Genetics's total funding is $32.6M.
Employee Data
- Atossa Genetics has 22 Employees.
- Atossa Genetics grew their employee count by 5% last year.
Atossa Genetics's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CEO, President and Chairman | Reveal Email/Phone |
2 | VP, Administration & HR | Reveal Email/Phone |
3 | VP, Administration & HR | Reveal Email/Phone |
4 | VP, Finance and Accounting | Reveal Email/Phone |
5 | Staff Accountant | Reveal Email/Phone |
6 | Chairman the Board and CEO | Reveal Email/Phone |
Atossa Genetics Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $0.9M | 6 | 0% | N/A | N/A |
#2 | $0.9M | 6 | 0% | N/A | N/A |
#3 | $5.1M | 33 | 6% | N/A | N/A |
#4 | $5.7M | 37 | 42% | N/A | N/A |
#5 | $1.4M | 18 | -10% | N/A | N/A |
#6 | $3.7M | 48 | -21% | $16M | N/A |
#7 | $1.1M | 7 | 0% | N/A | N/A |
#8 | $0.8M | 5 | -81% | N/A | N/A |
#9 | $2.5M | 16 | -27% | N/A | N/A |
#10 | $0.8M | 5 | -17% | N/A | N/A |
What Is Atossa Genetics?
We are a healthcare company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer.
keywords:N/A
$32.6M
Total Funding
22
Number of Employees
$1.7M
Revenue (est)
5%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Atossa Genetics News
A doctor collects fluid from each breast and sends the samples to Atossa’s CLIA-certified lab in Seattle, Washington. The National Reference Laboratory for Breast Health uses a proprietary analysis to study the fluid for precancerous cells. The results include treatment recommendations and prov ...
Atossa Genetics, Inc., a Seattle, WA-based health care company focused on the development and marketing of novel cellular and molecular diagnostic risk assessment products for breast cancer, has completed a $6.6m financing round. Investors remained undisclosed. The company intends to use the f ...
Atossa Genetics, which is developing testing technologies to detect the presence of breast cancer, has raised $6.6 million in new financing in an oversubscribed round. The Seattle company plans to use the funds to bring its MACST System to market, establish a new molecular diagnostics lab in the ...
Other Companies in Seattle
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $2.2M | 22 | -29% | N/A |
#2 | $2.2M | 22 | N/A | N/A |
#3 | $2.8M | 22 | N/A | N/A |
#4 | $1.5M | 22 | 0% | $1.9M |
#5 | $3.1M | 22 | N/A | N/A |